Baillif S - Search Results

1

Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease.

Pandiani C, Strub T, Nottet N, Cheli Y, Gambi G, Bille K, Husser C, Dalmasso M, Béranger G, Lassalle S, Magnone V, Pédeutour F, Irondelle M, Maschi C, Nahon-Estève S, Martel A, Caujolle JP, Hofman P, LeBrigand K, Davidson I, Baillif S, Barbry P, Ballotti R, Bertolotto C. Pandiani C, et al. Among authors: baillif s. Cell Death Differ. 2021 Jun;28(6):1990-2000. doi: 10.1038/s41418-020-00730-7. Epub 2021 Jan 18. Cell Death Differ. 2021. PMID: 33462406 Free PMC article.

2

Two-year outcomes of the APOLLON observational study of intravitreal aflibercept monotherapy in France in patients with diabetic macular edema.

Korobelnik JF, Daien V, Faure C, Tadayoni R, Giocanti-Aurégan A, Dot C, Kodjikian L, Massin P; APOLLON study investigators. Korobelnik JF, et al. Sci Rep. 2022 Oct 29;12(1):18242. doi: 10.1038/s41598-022-22838-1. Sci Rep. 2022. PMID: 36309572 Free PMC article.

3

[Effects of belimumab on ulcerative keratitis in Sjögren's syndrome: Report of two cases].

Elmaleh V, Ottavi M, Baillif S, Tieulié N. Elmaleh V, et al. Among authors: baillif s. J Fr Ophtalmol. 2023 Oct;46(8):e263-e264. doi: 10.1016/j.jfo.2023.03.009. Epub 2023 Aug 4. J Fr Ophtalmol. 2023. PMID: 37544782 French. No abstract available.

4

Ocular hypertension and intravitreal steroids injections, update in 2023. French guidelines of the French glaucoma society and the French ophthalmology society.

Dot C, Poli M, Aptel F, Labbe A, Kodjikian L, Baillif S, Bodaghi B, Denis P. Dot C, et al. Among authors: baillif s. J Fr Ophtalmol. 2023 Oct;46(8):e249-e256. doi: 10.1016/j.jfo.2023.05.001. Epub 2023 Jun 10. J Fr Ophtalmol. 2023. PMID: 37302867

5

Final 4-year results of the RAINBOW real-world study: intravitreal aflibercept dosing regimens in France in treatment-naïve patients with neovascular age-related macular degeneration.

Cohen SY, Dominguez M, Coscas F, Faure C, Baillif S, Oubraham H, Kodjikian L, Weber M; RAINBOW study investigators. Cohen SY, et al. Among authors: baillif s. Graefes Arch Clin Exp Ophthalmol. 2023 Apr;261(4):959-969. doi: 10.1007/s00417-022-05900-6. Epub 2022 Nov 18. Graefes Arch Clin Exp Ophthalmol. 2023. PMID: 36399178 Free PMC article. Clinical Trial.

6

Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome.

Dossarps D, Bron AM, Koehrer P, Aho-Glélé LS, Creuzot-Garcher C; FRCR net (FRenCh Retina specialists net). Dossarps D, et al. Am J Ophthalmol. 2015 Jul;160(1):17-25.e1. doi: 10.1016/j.ajo.2015.04.013. Epub 2015 Apr 16. Am J Ophthalmol. 2015. PMID: 25892127

7

Local recurrence after uveal melanoma proton beam therapy: recurrence types and prognostic consequences.

Caujolle JP, Paoli V, Chamorey E, Maschi C, Baillif S, Herault J, Gastaud P, Hannoun-Levi JM. Caujolle JP, et al. Among authors: baillif s. Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1218-24. doi: 10.1016/j.ijrobp.2012.10.005. Epub 2012 Nov 22. Int J Radiat Oncol Biol Phys. 2013. PMID: 23177670

8

Intravitreal dexamethasone 0.7-mg implant for radiation macular edema after proton beam therapy for choroidal melanoma.

Baillif S, Maschi C, Gastaud P, Caujolle JP. Baillif S, et al. Retina. 2013 Oct;33(9):1784-90. doi: 10.1097/IAE.0b013e31829234fa. Retina. 2013. PMID: 23652581

9

Outcomes After Proton Beam Therapy for Large Choroidal Melanomas in 492 Patients.

Bensoussan E, Thariat J, Maschi C, Delas J, Schouver ED, Hérault J, Baillif S, Caujolle JP. Bensoussan E, et al. Among authors: baillif s. Am J Ophthalmol. 2016 May;165:78-87. doi: 10.1016/j.ajo.2016.02.027. Epub 2016 Mar 3. Am J Ophthalmol. 2016. PMID: 26940166

10

Dry Eye Syndrome After Proton Therapy of Ocular Melanomas.

Thariat J, Maschi C, Lanteri S, Peyrichon ML, Baillif S, Herault J, Salleron J, Caujolle JP. Thariat J, et al. Among authors: baillif s. Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):142-151. doi: 10.1016/j.ijrobp.2017.01.199. Epub 2017 Jan 29. Int J Radiat Oncol Biol Phys. 2017. PMID: 28586953

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

150 results

Search Page